Sehhoon Park
Sehhoon Park
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-09-10 | NCT06830694 | |
| Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment | Non-Small Cell Lung Cancer Metastatic | Recruiting | Phase 2 | 2026-09-10 | NCT06106802 | |
| Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients | non-small cell lung carcinoma | Active, not recruiting | Phase 2 | 2026-07-28 | NCT05463224 |